- Home
- PRAX vs DNP Comparison
PRAX vs DNP Comparison
Compare PRAX & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- DNP
- Stock Information
- Founded
- PRAX 2015
- DNP 1986
- Country
- PRAX United States
- DNP United States
- Employees
- PRAX N/A
- DNP N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- DNP Investment Managers
- Sector
- PRAX Health Care
- DNP Finance
- Exchange
- PRAX Nasdaq
- DNP Nasdaq
- Market Cap
- PRAX 4.0B
- DNP 3.7B
- IPO Year
- PRAX 2020
- DNP N/A
- Fundamental
- Price
- PRAX $178.75
- DNP $10.08
- Analyst Decision
- PRAX Strong Buy
- DNP
- Analyst Count
- PRAX 13
- DNP 0
- Target Price
- PRAX $202.85
- DNP N/A
- AVG Volume (30 Days)
- PRAX 1.4M
- DNP 479.6K
- Earning Date
- PRAX 11-07-2025
- DNP 01-01-0001
- Dividend Yield
- PRAX N/A
- DNP 7.88%
- EPS Growth
- PRAX N/A
- DNP N/A
- EPS
- PRAX N/A
- DNP 2.30
- Revenue
- PRAX $7,765,000.00
- DNP $154,887,179.00
- Revenue This Year
- PRAX N/A
- DNP N/A
- Revenue Next Year
- PRAX $20.00
- DNP N/A
- P/E Ratio
- PRAX N/A
- DNP $4.26
- Revenue Growth
- PRAX 338.45
- DNP 3.30
- 52 Week Low
- PRAX $26.70
- DNP $8.69
- 52 Week High
- PRAX $205.89
- DNP $10.04
- Technical
- Relative Strength Index (RSI)
- PRAX 80.27
- DNP 61.02
- Support Level
- PRAX $164.75
- DNP $9.95
- Resistance Level
- PRAX $192.96
- DNP $10.02
- Average True Range (ATR)
- PRAX 11.99
- DNP 0.06
- MACD
- PRAX 13.57
- DNP 0.00
- Stochastic Oscillator
- PRAX 82.53
- DNP 100.00
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.